RNS Number : 9095X
Itaconix PLC
04 September 2025
 

For release: 07.00, 4 September 2025

 

Itaconix plc

("Itaconix" or the "Company")

Notice of Interim Results and Company Presentation

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in sustainable plant-based polymers used to decarbonize everyday consumer products, announces that its Interim Results for the year ended 30 June 2025 will be released on 15 September 2025.

Investor Meet Company presentation

A live presentation will be held on 15 September 2025 at 14:00 BST.  This presentation is open to all interested parties. Anyone can sign up for free to the Investor Meet Company platform and join the live presentation via:

https://www.investormeetcompany.com/itaconix-plc/register-investor

 

Questions can be submitted pre-event via your Investor Meet Company dashboard up until 14 Sept 2025, 09:00 BST, or at any time during the live presentation.

 

- Ends -

 

Enquiries:

Itaconix plc
John R. Shaw / Laura Denner
Tel: +1 603 775 4400

 

Rosewood (Financial PR)
John West / Llew Angus / Lily Pearce
Tel: +44 (0) 20 7653 8704

 

Canaccord Genuity (Nominated Adviser and Broker)
Adam James / Harry Pardoe
Tel: +44 (0) 20 7523 8000

 

About Itaconix

Itaconix plc develops and markets sustainable plant-based polymers that improve the safety, performance, and environmental profile of everyday consumer and industrial products. Its proprietary platform leverages itaconic acid to produce unique high-performance materials across multiple markets.

www.itaconix.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NORGZGGLVFMGKZM